These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12489326)

  • 41. Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
    Naba MR; Araj GF; Baban TA; Tabbarah ZA; Awar GN; Kanj SS
    J Infect Public Health; 2010; 3(3):113-7. PubMed ID: 20869671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
    Poirier R
    Presse Med; 1998 Sep; 27 Suppl 4():14-5. PubMed ID: 9798478
    [No Abstract]   [Full Text] [Related]  

  • 43. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Usefulness of pneumococcal antigen urinary testing in the intensive care unit?
    Camou F; Issa N; Bessede É; Mourissoux G; Guisset O
    Med Mal Infect; 2015 Aug; 45(8):318-23. PubMed ID: 26344817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A child with pneumonia caused by a multiresistant pneumococcus].
    Verhoef-Verhage EA; Fleer A
    Ned Tijdschr Geneeskd; 1990 Apr; 134(15):770-2. PubMed ID: 2336115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [An update of Streptococcus pneumoniae: from genomic to clinic].
    Wintenberger C
    Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286
    [No Abstract]   [Full Text] [Related]  

  • 47. Controversies in the treatment of pneumococcal community-acquired pneumonia.
    Feldman C; Anderson R
    Future Microbiol; 2006 Oct; 1(3):271-81. PubMed ID: 17661640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High level of resistance to levofloxacin of Streptococcus pneumoniae following fluoroquinolone therapy.
    d'Escrivan T; Roussel-Delvallez M; Alfandari S; Guery B
    Infection; 2003 Oct; 31(5):366. PubMed ID: 14556066
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
    Nuermberger EL; Bishai WR
    Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A clinical solution to antimicrobial resistance in community-acquired pneumonia: narrowing the spectrum of antimicrobial therapy: comment on "Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy".
    Yu VL
    Arch Intern Med; 2011 Jan; 171(2):172-3. PubMed ID: 21263107
    [No Abstract]   [Full Text] [Related]  

  • 51. Activity of tigecycline against Streptococcus pneumoniae, an important causative pathogen of community-acquired pneumonia (CAP).
    Hawser SP
    J Infect; 2010 Apr; 60(4):306-8. PubMed ID: 20144899
    [No Abstract]   [Full Text] [Related]  

  • 52. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
    Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Amoxicillin and Streptococcus pneumoniae].
    Soriano F; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):267. PubMed ID: 9044645
    [No Abstract]   [Full Text] [Related]  

  • 54. A testament to sustained macrolide efficacy.
    Bishai W
    Clin Infect Dis; 2003 Apr; 36(7):935-6; author reply 936-7. PubMed ID: 12652400
    [No Abstract]   [Full Text] [Related]  

  • 55. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
    Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
    Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Increasing antibiotic resistance of pneumococcus. Management of respiratory tract infections and meningitis].
    Kalin M; Eriksson M; Mölstad S; Prellner K
    Lakartidningen; 1997 Mar; 94(12):1061-4, 1067-8. PubMed ID: 9121238
    [No Abstract]   [Full Text] [Related]  

  • 57. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decrease in drug resistance in pneumococcal community-acquired pneumonia.
    Obando I; Arroyo L; Sanchez-Tatay D
    Chest; 2007 Jul; 132(1):359; author reply 359-60. PubMed ID: 17625101
    [No Abstract]   [Full Text] [Related]  

  • 59. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
    Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antibiotic resistance of Streptococcus pneumoniae isolated from patient with home care pneumonia].
    Martynova AV; Turkutiukov VB
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):81-3. PubMed ID: 15188568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.